2019
DOI: 10.1016/j.canlet.2019.01.027
|View full text |Cite
|
Sign up to set email alerts
|

miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
27
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 35 publications
4
27
0
Order By: Relevance
“…MiR-193a-3p is reported as a tumor suppressor in many types of cancers. It inhibits the migration and invasiveness of NSCLC [26]. In colorectal cancer, miR-193a-3p inhibited cell proliferation and promoted the apoptosis [27].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…MiR-193a-3p is reported as a tumor suppressor in many types of cancers. It inhibits the migration and invasiveness of NSCLC [26]. In colorectal cancer, miR-193a-3p inhibited cell proliferation and promoted the apoptosis [27].…”
Section: Discussionmentioning
confidence: 99%
“…Numerous targets of miR-193a-3p have been reported [26,28,32,33]. In this study, the TargetScan, miRNA.ORG, and miRDB software were used for the prediction of target genes.…”
Section: Discussionmentioning
confidence: 99%
“…Recently research has reported the inhibitory effect of miR-193-3p in a variety of tumors. In 2019, Liu et al (2019) found that a low level of miR-193a-3p expression was related to the increased expression of p21-activated kinase 4 (PAK4), p-Slug, and L1 cell adhesion molecule (L1CAM) in non-small cell lung cancer (NSCLC) and that miR-193a-3p inhibited the metastasis of NSCLC by repressing PAK4, p-Slug, and L1CAM. Through MTT assay and cell colony formation experiments, Yu et al (2019) showed that miR-193a-3p was downregulated in colorectal cancer cells, while miR-193a-3p's inhibitors promoted the proliferation and invasion of rectal cells.…”
Section: Discussionmentioning
confidence: 99%
“…MiR-133b promotes cell proliferation and metastasis in HCC by regulating splicing factor 3b subunit 4 (SF3B4) (Liu et al, 2018b). MiR-3650 suppresses HCC migration and epithelial-mesenchymal transition (EMT) by directly targeting neurofascin (Wu et al, 2019). could inhibit HCC invasion and metastasis (Liu et al, 2018a;Lou et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Previously, Xie et al reported that compared with normal brain tissue, Cyr61 is highly expressed in 66 cases of primary glioma, and Cyr61 expression is significantly related to tumor grade and patient survival [24]; CCND1, as an oncogene [25], is highly expressed in glioma, breast, and bladder cancer; the expression level of CCND1 is related to the malignant degree of tumors and has the effect of regulating the growth and proliferation of cancer cells [26]; Vimentin can reduce the expression of cell surface adhesion factors, thereby promoting the occurrence of cell migration and invasion. It is highly expressed in a variety of cancer tissues, especially in cancers with metastasis [27]; Slug originated from the neural crest and has been reported to be involved in regulating tumor cell invasion, migration, cell cycle, and other activities [28]. In this study, qPCR and Western blotting experiments were performed to demonstrate that CPP treatment of U251 can cause the downregulation of mRNA and protein expression levels of Cyr61, CCND1, Vimentin, and Slug to different degrees, suggesting that CPP plays critical roles in regulating the proliferation, apoptosis, migration, and invasion of gliomas through inhibiting the expression of GSK3β/βcatenin downstream oncogenes Cyr61, CCND1, Vimentin, and Slug.…”
Section: Discussionmentioning
confidence: 99%